{"product_id":"s-aureus-purified-cp8-bhp20900072","title":"S. Aureus Purified CP8","description":"\u003cstyle\u003e\n.bhp-desc{font-size:16px;color:#1a1a1a;line-height:1.7}\n.bhp-desc h2{font-size:18px;font-weight:700;color:#003366;margin:24px 0 10px;padding-bottom:6px;border-bottom:2px solid #003366}\n.bhp-desc p{margin:0 0 12px}\n.bhp-desc .bhp-spec-table{width:100%;border-collapse:collapse;margin:12px 0 18px}\n.bhp-desc .bhp-spec-table th{width:36%;text-align:left;padding:8px 12px;background:#e8f0fb;color:#003366;font-weight:600;vertical-align:top;border:1px solid #ccd9f0}\n.bhp-desc .bhp-spec-table td{padding:8px 12px;vertical-align:top;border:1px solid #ccd9f0}\n.bhp-desc .bhp-warning-box{background:#fff8e6;border-left:4px solid #e6a817;padding:10px 14px;margin:10px 0 14px;border-radius:0 4px 4px 0}\n.bhp-desc .bhp-cat-pill{display:inline-block;background:#003366;color:#fff;border-radius:20px;padding:3px 12px;font-size:13px;margin-bottom:10px}\n\u003c\/style\u003e\n\u003cdiv class=\"bhp-desc\"\u003e\n\u003ch2\u003eScientific Background\u003c\/h2\u003e\n\u003cp\u003eStaphylococcus aureus is a leading cause of community- and hospital-acquired infections worldwide. Together, capsular polysaccharide serotypes 5 (CP5) and 8 (CP8) account for surface polysaccharide expression in approximately 80% of clinical bloodstream isolates. CP8 is a linear polysaccharide with trisaccharide repeating units that differ from CP5 in the anomeric configuration of the N-acetyl-fucosamine residue. Serotype 8 strains, including Reynolds and O13, are prevalent among nosocomial and community-acquired bacteremia cases. CP8 is a clinically important vaccine antigen candidate and a reference reagent for serotype 8-specific OPA assays and anti-S. aureus antibody quantification.\u003c\/p\u003e\n\u003ch2\u003eProduct Description\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"bhp-cat-pill\"\u003eStaphylococcus\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eThis S. aureus Purified CP8 is a high molecular weight (Kav = 0.026) capsular polysaccharide purified from \u003cem\u003eS. aureus\u003c\/em\u003e strains Reynolds and O13. Supplied lyophilized in sterile water. Quality verified by CP8-specific monoclonal antibody 5A6.\u003c\/p\u003e\n\u003ch2\u003eProduct Specifications\u003c\/h2\u003e\n\u003ctable class=\"bhp-spec-table\"\u003e\n\u003ctr\u003e\n\u003cth\u003eCatalog Number\u003c\/th\u003e\n\u003ctd\u003e0581-PP-002\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFull Name\u003c\/th\u003e\n\u003ctd\u003eStaphylococcus aureus serotype 8 capsular polysaccharide (CP8)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eAbbreviation\u003c\/th\u003e\n\u003ctd\u003eCP8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eTarget\u003c\/th\u003e\n\u003ctd\u003eStaphylococcus aureus Serotype 8 Capsular Polysaccharide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eSource Strain\u003c\/th\u003e\n\u003ctd\u003eS. aureus Reynolds and O13\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eMolecular Size\u003c\/th\u003e\n\u003ctd\u003eHigh molecular weight (Kav = 0.026)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003ePurity\u003c\/th\u003e\n\u003ctd\u003e\u0026lt;1% protein; \u0026lt;1% nucleic acid; \u0026lt;1% phosphorus\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eQC Method\u003c\/th\u003e\n\u003ctd\u003eCP8-specific monoclonal antibody 5A6 (Western Blot); ELISA inhibition with CP8-specific rabbit antiserum\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eProduct Category\u003c\/th\u003e\n\u003ctd\u003eStaphylococcus\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eFormulation\u003c\/th\u003e\n\u003ctd\u003eLyophilized in sterile water\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eForm\u003c\/th\u003e\n\u003ctd\u003eLyophilized\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eApplications\u003c\/th\u003e\n\u003ctd\u003eELISA, Western Blot\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth\u003eStorage\u003c\/th\u003e\n\u003ctd\u003e-20°C\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003eSafety \u0026amp; Handling\u003c\/h2\u003e\n\u003cdiv class=\"bhp-warning-box\"\u003e\n\u003cstrong\u003eResearch Use Only (RUO).\u003c\/strong\u003e Not approved for human or veterinary use. Handle according to institutional biosafety guidelines. Commercial use requires written approval from Integrated BioTherapeutics, LLC.\u003c\/div\u003e\n\u003ch2\u003eRelated Products\u003c\/h2\u003e\n\u003cp\u003eExplore additional IBT Bioservices Staphylococcus aureus antigens available through BioHippo, including S. aureus Purified CP5 (BHP20900071) and recombinant S. aureus toxin proteins.\u003c\/p\u003e\n\u003c\/div\u003e","brand":"IBT Bioservices","offers":[{"title":"100 ug","offer_id":53402627703149,"sku":"0581-PP-002","price":650.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/0581-PP-002-1.png?v=1780508215","url":"https:\/\/www.ebiohippo.com\/products\/s-aureus-purified-cp8-bhp20900072","provider":"BioHippo","version":"1.0","type":"link"}